Archives of Clinical Infectious Diseases

Published by: Kowsar

Resistance Rate and Minimum Inhibitory Concentration of Metronidazole Among Helicobacter pylori Strains in Tehran, Iran

Mahnaz Shahabimehr 1 , Masoud Alebouyeh 2 , 3 , * , Nastaran Farzi 2 , 3 , 4 , Arash Mahboubi 5 , Reza Taslimi 6 and Mohammad Reza Zali 3
Authors Information
1 Department of Biology, Pharmaceutical Sciences Faculty, Islamic Azad University, Tehran, IR Iran
2 Foodborne and Waterborne Disease Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Disease, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Disease, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
5 Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
6 Department of Gastroenterology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: April 30, 2016, 11 (2); e34478
  • Published Online: March 22, 2016
  • Article Type: Brief Report
  • Received: November 28, 2015
  • Revised: February 27, 2016
  • Accepted: February 28, 2016
  • DOI: 10.5812/archcid.34478

To Cite: Shahabimehr M, Alebouyeh M, Farzi N, Mahboubi A, Taslimi R, et al. Resistance Rate and Minimum Inhibitory Concentration of Metronidazole Among Helicobacter pylori Strains in Tehran, Iran, Arch Clin Infect Dis. 2016 ; 11(2):e34478. doi: 10.5812/archcid.34478.

Abstract
Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Vaziri F, Najar Peerayeh S, Alebouyeh M, Mirzaei T, Yamaoka Y, Molaei M, et al. Diversity of Helicobacter pylori genotypes in Iranian patients with different gastroduodenal disorders. World J Gastroenterol. 2013; 19(34): 5685-92[DOI]
  • 2. Yadegar A, Mobarez Mohabati A, Alebouyeh M, Mirzaei T, Kwok T, Zali MR. Clinical relevance of cagL gene and virulence genotypes with disease outcomes in a Helicobacter pylori infected population from Iran. World J Microbiol Biotechnol. 2014; 30(9): 2481-90[DOI]
  • 3. Mirzaei T, Alebouyeh M, Shokrzadeh L, Aghdaei HA, Farzi N, Zojaji H, et al. Smoking, proton pump inhibitors and antibiotic administration as factors affecting direct screening of Helicobacter pylori infection amongs patients with dyspepsia. Arch Clin Infect Dis. 2014; 9(2)[DOI]
  • 4. Daryani Ebrahimi N, Taher M, Shirzad S. Helicobacter pylori infection: A review. Arch Clin Infec Dis. 2011; 6(1): 56-64
  • 5. Farzi N, Malekian T, Alebouyeh M, Vaziri F, Zali MR. Genotype Diversity and Quasispecies Development of Helicobacter pylori in a Single Host. Jpn J Infect Dis. 2015; 68(3): 176-80[DOI][PubMed]
  • 6. Shokrzadeh L, Alebouyeh M, Mirzaei T, Farzi N, Zali MR. Prevalence of multiple drug-resistant Helicobacter pylori strains among patients with different gastric disorders in Iran. Microb Drug Resist. 2015; 21(1): 105-10[DOI]
  • 7. Toracchio S, Cellini L, Di Campli E, Cappello G, Malatesta MG, Ferri A, et al. Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. Aliment Pharmacol Ther. 2000; 14(12): 1639-43[PubMed]
  • 8. De Francesco V, Giorgio F, Hassan C, Manes G, Vannella L, Panella C, et al. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis. 2010; 19(4): 409-14[PubMed]
  • 9. Sirous M, Mehrabadi JF, Daryani NE, Eshraghi S, Hajikhani S, Shirazi MH. Prevalence of antimicrobial resistance in Helicobacter pylori isolates from Iran. Afr J Biotechnol. 2013; 9(36)
  • 10. Yang JC, Lu CW, Lin CJ. Treatment of Helicobacter pylori infection: current status and future concepts. World J Gastroenterol. 2014; 20(18): 5283-93[DOI][PubMed]
  • 11. Alebouyeh M, Yadegar A, Farzi N, Miri M, Zojaji H, Gharibi S, et al. Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes. Gastroenterol Hepatol Bed Bench. 2015; 8-5[PubMed]
  • 12. Asge Standards of Practice Committee , Early DS, Ben-Menachem T, Decker GA, Evans JA, Fanelli RD, et al. Appropriate use of GI endoscopy. Gastrointest Endosc. 2012; 75(6): 1127-31[DOI][PubMed]
  • 13. Asge Standards of Practice Committee , Sharaf RN, Shergill AK, Odze RD, Krinsky ML, Fukami N, et al. Endoscopic mucosal tissue sampling. Gastrointest Endosc. 2013; 78(2): 216-24[DOI][PubMed]
  • 14. Kahlmeter G, Brown DF, Goldstein FW, MacGowan AP, Mouton JW, Odenholt I, et al. European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing. Clin Microbiol Infect. 2006; 12(6): 501-3[DOI][PubMed]
  • 15. Torres-Debat ME, Perez-Perez G, Olivares A, Fernandez L, Raisler K, Gonzalez N, et al. Antimicrobial susceptibility of Helicobacter pylori and mechanisms of clarithromycin resistance in strains isolated from patients in Uruguay. Rev Esp Enferm Dig. 2009; 101(11): 757-62[PubMed]
  • 16. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007; 56(6): 772-81[DOI][PubMed]
  • 17. Haghi Tomatari F, Mohabbati Mobarez A, Amini M, Hosseini D, Talebi Bezmin Abadi A. Helicobacter pylori resistance to metronidazole and clarithromycin in dyspeptic patients in Iran. Iran Red Crescent Med J. 2010; 12(4): 409
  • 18. Farshad S, Alborzi A, Japoni A, Ranjbar R, Hosseini Asl K, Badiee P, et al. Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran. World J Gastroenterol. 2010; 16(45): 5746-51[PubMed]
  • 19. Mirzaei N, Poursina F, Faghri J, Talebi M, Khataminezhad MR, Hasanzadeh A, et al. Prevalence of resistance of Helicobacter pylori strains to selected antibiotics in Isfahan, Iran. Jundishapur J Microbiol. 2013; 6(5)[DOI]
  • 20. Kohanteb J, Bazargani A, Saberi-Firoozi M, Mobasser A. Antimicrobial susceptibility testing of Helicobacter pylori to selected agents by agar dilution method in Shiraz-Iran. Indian J Med Microbiol. 2007; 25(4): 374-7[PubMed]
  • 21. Falsafi T, Mobasheri F, Nariman F, Najafi M. Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the pediatric medical center of Tehran, Iran. J Clin Microbiol. 2004; 42(1): 387-9[PubMed]
  • 22. Mohammadi M, Doroud D, Mohajerani N, Massarrat S. Helicobacter pylori antibiotic resistance in Iran. World J Gastroenterol. 2005; 11(38): 6009-13[PubMed]
  • 23. Sayadi S, Darboue M, Dabiri H, Shokrzadeh L, Mirzaee T, Alebouyeh M, et al. Study of antibiotic resistant H. pylori isolated from Iranian patients during 2009-2010. Healthmed. 2011; 5(6): 1970-6
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments